AEMD: הכנסות ממכירות החברה Aethlon Medical, Inc.

Aethlon Medical (AEMD) is expanding rapidly by implementing the innovative Hemopurifier system for the physical removal of tumor markers and viruses from the bloodstream. Strong recognition of the method among virologists confirms the effectiveness of clearing exosomes from the body. The integration of this technology into intensive care practice establishes a unique standard for the therapy of resistant infections. The company's sales time series demonstrates revenue dynamics, where 0.00 determines the current status of the parameter.

Aethlon Medical (AEMD) focuses on developing innovative Hemopurifier systems for filtering blood of tumor markers and pathogens. This indicator captures daily revenue volume, allowing for the separation of random spikes from a sustainable trend; analyzing the company's product sales helps investors determine the fundamental stability of cash flows and avoid overvaluing the asset based on short-term market impulses.